Home > Insider Trading > Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. (XENE) - News

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

1 - 10
Next >>

Hedge Funds Are Done Buying Xenon Pharmaceuticals Inc (XENE)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...

Keep Reading →

September 28th, 2020 - Hedge Funds News

Did Hedge Funds Make The Right Call On Xenon Pharmaceuticals Inc (XENE) ?

Keep Reading →

July 12th, 2020 - Hedge Funds News

Hedge Funds Aren’t Done Buying Xenon Pharmaceuticals Inc (XENE)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even...

Keep Reading →

June 8th, 2020 - Hedge Funds News

Did Hedge Funds Drop The Ball On Xenon Pharmaceuticals Inc (XENE) ?

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons. Nevertheless, the data...

Keep Reading →

December 11th, 2019 - Hedge Funds News

Is Xenon Pharmaceuticals Inc (XENE) A Good Stock To Buy?

"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up...

Keep Reading →

November 11th, 2019 - Hedge Funds News

Hedge Funds Have Never Been This Bullish On Xenon Pharmaceuticals Inc (XENE)

Does Xenon Pharmaceuticals Inc (NASDAQ:XENE) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out...

Keep Reading →

June 14th, 2019 - Hedge Funds News

Xenon Pharmaceuticals Inc (XENE): Are Hedge Funds Right About This Stock?

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards...

Keep Reading →

December 19th, 2018 - Hedge Funds News

Granite Point Capital’s Returns, AUM, and Holdings

Warren Lammert founded Granite Point Capital, a long/short hedge fund with a focus on small-cap companies, in January 2004. The fund is headquartered in Boston, Massachusetts, and Mr. Lammert is its portfolio...

Keep Reading →

November 16th, 2018 - Hedge Fund Analysis Hedge Funds News

How Xenon Pharmaceuticals Inc (XENE) Stacks Up Against Its Peers

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...

Keep Reading →

December 20th, 2016 - Hedge Funds News

Xenon Pharmaceuticals Inc. (XENE): Biotechnology Value Fund Adds More Shares

Mark Lampert's Biotechnology Value Fund reported raising its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) to 3.11 million shares, which account for 17.9% of the company's outstanding stock, via...

Keep Reading →

September 12th, 2016 - Hedge Funds News